Understanding Autoimmune Disease: What It Is, Who Gets It, and Why
Patients ask me to explain lupus in one sentence more often than they ask me anything else. Usually they've just told a friend or a colleague they have it, watched the person's face go blank, and realized they can't actually explain their own illness.
So let's start there, and build outward.
The one-sentence version
Auto means self. Immune refers to your immune system. An autoimmune disease is one in which the immune system — the apparatus built to identify and destroy threats — begins attacking your own cells instead.
That's it. That's the whole category. Everything else is a question of which cells are attacking and which tissues are attacked
Rheumatoid arthritis: the joints. Hashimoto's thyroiditis: the thyroid. Crohn's disease: the digestive tract. Type 1 diabetes: the insulin-producing cells of the pancreas. Multiple sclerosis: the insulation around nerves. More than eighty conditions are recognized as autoimmune, and the list has grown as our tools have improved.
Lupus, specifically
Lupus- properly, systemic lupus erythematosus- is the one I'm asked about most, partly because it's genuinely hard to explain and partly because it looks different in every person who has it.
In lupus, the immune system generates antibodies against components of the cell nucleus, , the control center in nearly every cell in the body. This single fact explains why lupus is so unpredictable: the target isn't confined to one organ. It's everywhere.
What follows is a disease that can show up as:
- Skin and rashes, including the facial rash the illness is named for, and marked sensitivity to sunlight
- Joint pain and swelling, often the first thing patients notice
- Kidney involvement (lupus nephritis), one of the most consequential manifestations and a major reason we monitor urine and kidney function closely
- Cardiovascular disease, which is substantially elevated in lupus and is under-appreciated by patients and physicians alike
- Neurological and cognitive involvement, ranging from headaches and brain fog to inflammation affecting the brain directly
- Blood abnormalities, clotting problems, fatigue, and fevers
Here is the part that matters clinically and that patients almost never hear said out loud: your lupus is not the same disease as the lupus of the person next to you. Two people with identical diagnoses and overlapping antibody profiles can have entirely different illnesses — one primarily renal, one primarily cutaneous, one primarily neurological. They will respond differently to the same medication. Any treatment plan that doesn't begin from that fact is starting from the wrong place.
How much of this is genetic?
This is the question I get from every newly diagnosed patient, usually phrased as: did I do this to myself, and will I give it to my children?
We have an unusually clean way to answer it. Identical twins share essentially the same genome. So if a disease were purely genetic, then whenever one identical twin had it, the other would too — 100% concordance.
In lupus, twin concordance is roughly 25%.
Sit with that number, because it reframes everything. If your identical twin has lupus, you have about a one-in-four chance of developing it. Genetics load the gun in maybe a quarter of the story, but something else pulls the trigger.
That something else is epigenetics: the set of mechanisms by which environment and experience determine whether a given gene is switched on or off. Your genome is the hardware. Epigenetics is what's actually running.
I lived through the moment this became clear. In the 1990s, the race to sequence the human genome was the most exciting advance in medicine, and I followed it obsessively. When the draft sequence arrived, many of us assumed we were three to five years from a therapeutic revolution — decode the genes, find the broken ones, fix them.
Then came the genome-wide association studies. Take two hundred lupus patients, sequence their genome and ind the lupus gene. But, the answer that came back was not one simple gene, but families of genes, each contributing a small increment of risk, and — more importantly — the crucial variable was whether those genes were being activated at all.
I've come to think epigenetics is the more interesting science, because epigenetics is modifiable and your genome is not. The environment you grew up in, the infections you've had, the food you eat, the sleep you get, the stress you carry, the chemicals you're exposed to — these participate in determining gene expression. There is even a growing literature suggesting that severe trauma and stress in mothers leave epigenetic marks that are transmitted to children — not through the gene sequence, but through the regulation of it.
Some of of these factors are preventable and reversible, which is precisely why lifestyle is not a soft topic in my clinic.
Is autoimmune disease actually increasing?
I want to answer this carefully, because it's the kind of question where confident answers are usually wrong.
The prevalence numbers are rising in scientifically validated surveys. That much is well documented.
But part of that rise is almost certainly an artifact. We test more. We test better. Patients have more access, present earlier, and are more likely to be correctly labeled. Conditions that would have been dismissed as neurosis in 1975 now get a proper diagnosis. Some portion of the increase is us getting better at counting.
My honest read, after decades in this field: some of it is counting, and some of it is real. I do believe there has been a genuine increase in autoimmune disease over the past several decades. But anyone who tells you they can precisely apportion how much is measurement and how much is biology is telling you more than the data supports.
Who gets it
Women, disproportionately. Autoimmune disease as a category falls more heavily on women, and in lupus the imbalance is striking — most published series report women outnumbering men by a wide margin. The mechanisms are still being worked out: sex hormones, X-chromosome gene dosage, and immune differences all appear to contribute.
Younger than most people assume. Patients often think of lupus as a disease of middle age, but the main incidence peak is in the twenties and thirties. Diagnosis frequently comes later — a patient diagnosed at thirty-nine may well have had active disease for years — which distorts the perception.
And here is the finding that changed how I think about all of it. In the United States, lupus presents more severely in Black Americans and Native Americans, with higher rates of kidney and neurological involvement.
But when you look at lupus in Africa’s population, the disease is not as severe as it is in African Americans.
Substantially shared ancestry, but with markedly different disease manifestations. Whatever is driving that difference, it is not encoded in the genome — it lives in environment, exposure, stress, food, healthcare access, and the accumulated biology of how people live. It is the epigenetic argument, written at population scale.
What this means for you
If you're newly diagnosed, here are three things to follow:
First, get tested and keep getting tested. I hear "I'd rather not know" fairly often, and I understand the impulse, but it's the wrong instinct. Lupus damages organs quietly. Kidney involvement can advance a long way before you feel it. Detection is the entire game, and we live in a moment when there's a great deal we can do — if we know.
Second, your diagnosis is a starting point, not a description. The label tells you the broad scope of the disease, but it doesn't tell you which organs, which severity, which trajectory, or which treatment. That takes time and careful observation.
Third, roughly three-quarters of the story is not your genes. I don't say that to imply you caused your illness — you didn't. I say it because there is meaningful territory where your choices and environment act on the same pathways the medications act on. Food, sleep, stress regulation, movement, and how your autonomic nervous system is functioning all touch the inflammatory machinery. It's a second lever for disease regulation, that most patients are never told exists.
I tell patients who are struggling and need something to hold onto: let's get through the next five years. The pace of work in this field right now genuinely justifies optimism. In the meantime, we manage what's in front of us, we protect the organs, and we use every tool available.
Disclaimer: This article is educational and is not medical advice. It does not establish a physician-patient relationship. Autoimmune disease requires individualized evaluation and management — please work with a qualified physician.